Pfizer STN 25 mg (Sutent 25 mg)
Generic Name: sunitinib
Pill with imprint Pfizer STN 25 mg is Brown & Orange, Capsule-shape and has been identified as Sutent 25 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer STN 25 mg
Sutent
- Generic Name:
- sunitinib
- Imprint:
- Pfizer STN 25 mg
- Strength:
- 25 mg
- Color:
- Brown & Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
VEGF/VEGFR inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Pfizer U.S. Pharmaceuticals Group
- Inactive Ingredients:
- mannitol
croscarmellose sodium
povidone k25
magnesium stearate
gelatin
titanium dioxide
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
shellac
propylene glycol
sodium hydroxide
povidone
Note: Inactive ingredients may vary.
More about Sutent (sunitinib)
- Sutent Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 19 Reviews
- Drug class: multikinase inhibitors
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
